Sandra D Quartner, MD | |
6569 N Charles St, Ste 304, Balto, MD 21204 | |
(410) 339-3904 | |
(410) 825-4076 |
Full Name | Sandra D Quartner |
---|---|
Gender | Female |
Speciality | Obstetrics & Gynecology |
Location | 6569 N Charles St, Balto, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639274517 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | D0019922 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sandra D Quartner, MD 6569 N Charles St, Ste 304, Balto, MD 21204 Ph: (410) 339-3904 | Sandra D Quartner, MD 6569 N Charles St, Ste 304, Balto, MD 21204 Ph: (410) 339-3904 |
News Archive
Building on a 30-year, three-generation study of depressed individuals, their children and offspring, a study published in the journal Psychiatry Research: Neuroimaging provides a better understanding of the familial risk for depression and the role neuroplasticity might have in increasing the risk of developing depression.
Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems, announced today that beginning in September 2011, select Publix Super Markets (Publix) in the Southeast region will be offering flu season immunizations utilizing the Bioject ZetaJet™. Publix will be conducting evaluations in 52 stores in Florida, Georgia, Alabama and South Carolina.
Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that an estimated 13.5 million adults would now be considered as having achieved goal blood pressure, primarily older adults, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions.
In cell culture, loperamide, a drug commonly used against diarrhea, proves effective against glioblastoma cells. A research team at Goethe University has now unraveled the drug's mechanisms of action of cell death induction and – in doing so – has shown how this compound could help attack brain tumors that otherwise are difficult to treat.
Better regulation is urgently needed for genetic tests, particularly those marketed directly to the public, argue researchers in this week's BMJ.
› Verified 6 days ago